HALDOL

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Cyprus, Ecuador, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Malta, Mexico, Netherlands, Tunisia, UK.

Active ingredients

The drug HALDOL contains one active pharmaceutical ingredient (API):

1	Haloperidol UNII 6387S86PK3 - HALOPERIDOL LACTATE
	Haloperidol is an antipsychotic belonging to the butyrophenones group. It is a potent central dopamine type 2 receptor antagonist, and at recommended doses, has low alpha-1 antiadrenergic activity and no antihistaminergic or anticholinergic activity.
	Read more about Haloperidol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05AD01	Haloperidol	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AD Butyrophenone derivatives
Discover more medicines within N05AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	514501201116310, 514501203119317, 514501205154314, 514501206134317
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	01856849, 02084403, 02084432, 02478148, 14005478
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	25.938-09-04
FR	Base de données publique des médicaments	61490049, 61697400, 62237643, 65374654
GB	Medicines & Healthcare Products Regulatory Agency	23875
HK	Department of Health Drug Office	19027
IE	Health Products Regulatory Authority	27050
IL	מִשְׂרַד הַבְּרִיאוּת	1379, 2877, 3470, 4260, 7258
IT	Agenzia del Farmaco	025373059
MT	Medicines Authority	AA565/15203
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	63972, 64181
NL	Z-Index G-Standaard	12123498, 12123536, 12327301, 12327328, 12358118
NL	Z-Index G-Standaard, PRK	151130, 16578, 16632, 16640, 17965, 5576
TN	Direction de la Pharmacie et du Médicament	5740051, 5740052, 5740054
US	FDA, National Drug Code	50458-255